Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • 1mg acquires Dawailelo...

    1mg acquires Dawailelo to strengthen pharmacy operations

    Written by Ruby Khatun Khatun Published On 2017-09-04T09:30:32+05:30  |  Updated On 4 Sept 2017 9:30 AM IST
    1mg acquires Dawailelo to strengthen pharmacy operations

    New Delhi: 1mg, India’s largest digital health platform, has announced that it has acquired Dawailelo.com, a technology-based facilitator in the healthcare space that helps individuals buy medicines, consult with doctors and get lab tests done.


    “We are very keen on building a pan India presence rapidly. The team at Dawailelo has done a great job understanding the requirements of the customers and has created a unique model that has shown great promise for Tier II and III cities,” said Prashant Tandon, CEO, 1mg.


    The team would be working with the 1mg e-Pharmacy team, reporting to COO Tanmay Saksena.


    “With Dawailelo team on board, in the coming months we would expand our footprint to cover most parts of India”, said Tanmay.


    Dawailelo was co-founded by the duo- Aditya Agrawal (CEO) and Arpit Sarin (COO) in 2013. Agrawal has an MBA in marketing from Banaras Hindu University and co-founder Arpit Sarin has a bachelor’s degree in mechanical engineering.


    Dawailelo CEO Aditya Agrawal said, “We’re looking forward to working with the 1mg team and establish an efficient and stable digital healthcare channel in the Tier II & Tier III towns of the country.”


    Arpit Sarin, COO, Dawailelo added, “It’s a good time to work in collaboration with the 1mg team and consolidate our efforts towards the common goal of delivering best healthcare services to the people.”


    1mg launched in 2015 and is India’s premier digital health platform with over 10 million app downloads. It is the trusted health partner for all Indians and its mission is to make healthcare accessible, understandable and affordable for a billion Indians. It enables consumers to learn more about their medicines and also find more cost-effective substitutes.


    Its diagnostics service brings transparency and price-effectiveness to lab tests. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price.


    In July 2017, 1mg closed a financing round of ~$15M, led by HBM Healthcare Investments with participation from other existing investors Maverick, Sequoia India, Omidyar & Kae Capital. The company had previously raised funding from Maverick Capital Ventures, HBM Healthcare Investments, Sequoia Capital India, Omidyar Network, Kae Capital etc.


    The company had previously raised funding from Maverick Capital Ventures, HBM Healthcare Investments, Sequoia Capital India, Omidyar Network, Kae Capital etc.

    1mgAcquiresAcquisitionAditya AgrawalArpit SarinDawaileloDawailelo.comDigital Health platformHBM Healthcare InvestmentsHealthcareoperationspharmacyPrashant TandonSequoia IndiastrengthenTanmay Saksena
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok